Cerveau Technologies

Press ReleasesCerveau Technologies, Inc. Announces Initiation of Japanese Phase I StudyNovember 14, 2019 — Read MoreCerveau Technologies, Inc. Announces a Partnership with LuMind IDSC Foundation to Study Accumulation of Neurofibrillary Tau in Down SyndromeMay 9, 2019 — Read MoreCerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging AgentMarch 22, 2019 — Read MoreCerveau Technologies, Inc. and Institut de Radiofarmacia Aplicada de Barcelona, S.L. Announce Agreement to Manufacture Investigational Tau LigandFebruary 19, 2019 — Read MoreCerveau Technologies, Inc. to Support a First Clinical Study in Asia of a Novel Biomarker of Alzheimer’s DiseaseDecember 13, 2018 — Read MoreCerveau Technologies Inc. Signs Research Agreement with Ionis Pharmaceuticals, Inc. for Novel Tau Imaging Agent— Read MoreSeptember 24, 2018 — Business WireCerveau Technologies Inc. Announces Expanded Research Access to Novel Tau Imaging Agent— Read MoreAugust 07, 2018 — Business WireCerveau Technologies, Inc. Signs Research Agreement with Tokyo Metropolitan Institute of Gerontology, Japan— Read MoreMay 15, 2018 — Business WireCerveau Technologies, Inc. Signs Research Agreement with Massachusetts General Hospital— Read MoreFebuary 8, 2018 — Business WireCerveau Technologies, Inc. Signs Research Agreement with University of Pittsburgh— Read MoreJanuary 16, 2018 — Business WireCerveau Technologies, Inc. Signs Research Agreement with KU Leuven University, Belgium— Read MoreDecember 14, 2017 — Business WireCerveau Technologies, Inc. Signs Research Agreement with VU Medical Center Amsterdam— Read MoreDecember 06, 2017 — Business WireCerveau Technologies, Inc. and Enigma Biomedical Group, Inc., Sign Research Agreement with Centre for Addiction and Mental Health (CAMH), Toronto— Read MoreNovember 20, 2017 — Business WireCerveau Technologies, Inc. Signs Research Agreement with Houston Methodist— Read MoreNovember 8, 2017 — Business WireCerveau Technologies and Sinotau Pharmaceutical Group Announce Sinotau’s Achievement of a Major Milestone in China Strategy— Read MoreNovember 2, 2017 — Business WireCerveau Technologies, Inc. Announces a Partnership with Landmark Alzheimer’s Disease DIAN-TU Trial— Read MoreOctober 30, 2017 — Business WireCerveau Technologies Inc. Signs License and Supply Agreement with AbbVie for Novel Tau Imaging Agent — Read More October 23, 2017 — Business WireCerveau Technologies, Inc. Announces Collaboration with Banner Health— Read More September 19, 2017 -- BUSINESS WIRE Cerveau Technologies Inc. Signs Collaboration Agreement with H. Lundbeck A/S for Novel Tau Imaging Agent— Read MoreSeptember 14, 2017 -- BUSINESS WIREImanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand — Read MoreJune 30, 2017 — Business WireCerveau Technologies, Inc. Announces Collaboration with NYU Langone Medical Center — Read MoreJune 26, 2017 — Business WireCerveau Technologies, Inc. Announces FDA Acceptance of Investigational New Drug (IND) for Tau Imaging Agent MK-6240— Read MoreJune 16, 2017 — Business WireCerveau Technologies, Inc. Collaborates With Singapore’s Clinical Imaging Research Centre— Read MoreMay 24, 2017 — Business WireCerveau Technologies, Inc. Signs Clinical Supply Agreement with Merck for Investigational Tau Imaging Agent— Read MoreMay 4, 2017 — Business WireCerveau Technologies, Inc. Executes a Binding Term Sheet with Sinotau Pharmaceutical Group for Novel Investigational Tau Imaging Agent— Read MoreMarch 17, 2017 — Business WireCerveau Tapped for Alzheimer's Research— Read MoreMarch 7, 2017 — Outsourcing PharmaCerveau Technologies, Inc. Signs Research Agreement with Wisconsin Alzheimer's Disease Research Center— Read MoreMarch 6, 2017 — Business WireCerveau Technologies, Wisconsin Alzheimer's Center Ink Research Deal— Read MoreMarch 6, 2017 — Drug Delivery BusinessCerveau Technologies, Inc. Signs Manufacturing Agreement with Siemens' PETNET Solutions for Investigational Tau Imaging Agent— Read More February 16, 2017 — Imaging Technology NewsCerveau Technologies, Inc. Signs Manufacturing Agreement with Siemens' PETNET Solutions for Investigational Tau Imaging Agent— Read More February 9, 2017 — Business WireCerveau Technologies, Inc. Signs License Agreement with Merck for Novel Investigational Tau Imaging Agent— Read MoreJanuary 5, 2017 — Business Wiremade with Lay Theme